Showing results (1971-1980 of 6,956) with videos related to
Sort By:
Pageof 696
Intensive Care Medicine|July 3, 2008
Early increases in microcirculatory perfusion during protocol-directed resuscitation are associated with reduced multi-organ failure at 24 h in patients with sepsisStephen Trzeciak, Jonathan V McCoy, R Phillip Dellinger, et al.Intensive Care Medicine|September 21, 2007
Do antibiotics administered at the time of central venous catheter removal interfere with the evaluation of colonization?Bertrand Souweine, Anne Elisabeth Heng, Claire Aumeran, et al.Intensive Care Medicine|July 26, 2008
A comparison of epinephrine and norepinephrine in critically ill patientsJohn A Myburgh, Alisa Higgins, Alina Jovanovska, et al.Intensive Care Medicine|July 29, 2008
Intensive insulin therapy: enhanced Model Predictive Control algorithm versus standard careJeremy J Cordingley, Dirk Vlasselaers, Natalie C Dormand, et al.Intensive Care Medicine|April 26, 2007
Internal jugular venous catheter-related bacteremia according to central and posterior accessesLeonardo Lorente, Alejandro Jiménez, Juan Castedo, et al.Intensive Care Medicine|July 25, 2008
Acute hyperammonemic encephalopathy in adult onset ornithine transcarbamylase deficiencyOgee Mer Panlaqui, Khoa Tran, Amanda Johns, et al.Intensive Care Medicine|March 30, 2012
Prevalence and outcome of cirrhosis patients admitted to UK intensive care: a comparison against dialysis-dependent chronic renal failure patientsAlastair J O'Brien, Cathy A Welch, Mervyn Singer, et al.Intensive Care Medicine|March 30, 2012
Remifentanil/midazolam versus fentanyl/midazolam for analgesia and sedation of mechanically ventilated neonates and young infants: a randomized controlled trialLars Welzing, Andre Oberthuer, Shino Junghaenel, et al.Intensive Care Medicine|March 30, 2012
Quantification of recirculation as an adjuvant to transthoracic echocardiography for optimization of dual-lumen extracorporeal life supportErik P J Körver, Yuri M Ganushchak, Antoine P Simons, et al.Intensive Care Medicine|October 4, 2021
Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trialPierre-François Laterre, Peter Pickkers, Gernot Marx, et al.Pageof 696